BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Synephrine

a vasoconstrictor in circulatory failure, asthma, nasal congestion, and glaucoma.

298+ PubMed studies analyzed · 19 RCTs · Evidence Score: 41.7

Research Domains

Synephrine has been studied across 20 research domains including 🔥 Metabolic, 🧠 Focus & Attention, 🔬 Inflammation, ❤️ Cardiovascular, 🌤️ Mood & Depression. The primary research focus is 🔥 Metabolic with 13% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Synephrine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

idebenone
2 shared targets
Thiamphenicol
2 shared targets
Aztreonam
2 shared targets
Chlormethiazole
2 shared targets
Pinacidil
2 shared targets
Midodrine
2 shared targets
Orotic
2 shared targets
Lactic
2 shared targets
doxylamine
2 shared targets
Iodine
2 shared targets
Loading evidence profile...

This evidence profile for Synephrine is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.